Dr. David J. Ballard Appointed Chief Clinical Officer of the Mentice Group

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

January 9, 2019

Dr. David J. Ballard, an endovascular specialist, has been appointed Chief Clinical Officer and Executive Vice President of the Mentice Group.

Dr. David J. Ballard was previously appointed an independent member of the Mentice board of directors in October 2018. Mentice is a provider of endovascular performance solutions.

“I am excited to join the Mentice executive team, in addition to continuing to engage my existing role on the Mentice board,” says Dr. Ballard. “I have spent the last couple of months educating myself on the opportunities to leverage Mentice solutions to reduce harm to patients, and to make health care more affordable. We have excellent opportunities to make significant contributions towards achieving both these objectives in partnership with healthcare systems across the world.”

Dr. David J. Ballard (M.D., M.S.P.H., Ph.D., F.A.C.P.) is a health care executive with proven expertise in improving healthcare value and organizational financial performance, while providing international thought leadership. Dr. Ballard was recognized by Becker’s Hospital Review as one of the top 50 experts leading the field of patient safety in 2015, 2016, 2017 and 2018.

A past president of the International Society for Quality in Health Care, Dr. Ballard in 2008 received the Distinguished Alumnus Award from the University of North Carolina School of Medicine. Widely recognized as a scholar in health care quality and value, his two books on health care quality leadership have received Shingo Awards for their contributions to operational excellence.

Dr. Ballard served the past 19 years as Chief Quality Officer of Baylor Scott & White Health, the largest health care system in Texas. He has also served in leadership roles at Emory University (1994-1999), University of Virginia (1991-1994) and the Mayo Clinic. He holds degrees in economics, epidemiology and medicine from the University of North Carolina where he was a John Motley Morehead Scholar.

Dr. Ballard trained in internal medicine at the Mayo Clinic and served from 1986-91 on the Mayo staff as Consultant, Associate Professor and Head of the Section of Health Services Evaluation, where he now serves as Healthcare Policy Section Editor for the Mayo Clinic Proceedings. Dr. Ballard is a member of the Chancellor’s Global Leadership Council at the University of North Carolina where he is also Adjunct Professor of Health Policy and Management in the UNC Gillings School of Global Public Health.

“I’m thrilled to welcome Dr. Ballard to our team,” says Goran Malmberg, Group CEO of Mentice. “Dr. Ballard will help drive our engagement with health systems, and I cannot think of a better person for this role. Mentice has a unique technology and a market-leading position with premier medical device corporations and academic institutes worldwide. We believe the largest opportunity for our solutions is within the field of continuous practice and with leading health systems—areas where we are just beginning.”

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.